Dov A. Goldstein Md.

Director, MELINTA THERAPEUTICS, INC. /NEW/.

Companies

BioAge Labs, Inc.Chief financial officer Sep 25, 2024 to now¹
Coya Therapeutics, Inc.Board member Dec 28, 2022 to now²
Gain Therapeutics, Inc.Board member Mar 17, 2021 to now³
NeuBase Therapeutics, Inc.Board member Jul 16, 2019 to Sep 12, 2022⁴
ADMA Biologics (United States)Board member Feb 15, 2012 to May 1, 2020⁵
Esperion TherapeuticsBoard member Jun 25, 2013 to Jun 8, 2018⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARBioAge Labs, Inc., Chief financial officer
2
SEC EDGARCoya Therapeutics, Inc., Board member
3
SEC EDGARGain Therapeutics, Inc., Board member
4
SEC EDGARNeuBase Therapeutics, Inc., Board member
5
SEC EDGARADMA Biologics (United States), Board member
6
SEC EDGAREsperion Therapeutics, Board member